The Curant Health Patient Management Program

works proactively with patients to provide specialty pharmaceuticals and therapy management support services to patients with a variety of chronic conditions such as HIV/ AIDS, hepatitis C and IBD, just to name a few.

Our pharmacists and nurses work directly with patients enrolled in this program to assess and help eliminate barriers to adherence, to provide patient education and to monitor disease progression and remission. This wholistic approach from our clinicians aims to help patients achieve optimal therapeutic outcomes, thus avoiding adverse medication events and unnecessary costs.

Our program promotes enhanced patient understanding, increased adherence to medication regimens, prevention and detection of adverse medication events and pattern identification of over-use and under-use of prescription medications.

Personalized Healthcare And Improved Outcomes In HIV Treatment

Our patient, Robert W. had only months to live. Presenting with a CD4 count of only 21, and weighing 98 pounds, his HIV had progressed to Stage 3 AIDS. Though he wanted to get better, he had to make decisions HIV positive patients must make all too frequently: which medications should he buy to manage his HIV treatment based on what he could afford?

Read more about how Curant Health partnered with Robert and his healthcare providers at Virginia Commonwealth University to get Robert back on the right track.

C The Cure™ Program Details

Our patient management program offers many benefits to facilitate hepatitis C treatment initiation and to provide the best possible health outcomes for patients.

A First Of Its Kind Study With IBD Patients

In a groundbreaking study conducted by Curant Health and Johns Hopkins Medicine’s Meyerhoff Inflammatory Bowel Disease Center, our clinicians sought to determine the effects of an IBD Patient Management program in comparison with standard care in a large university hospital outpatient setting.

Patient management for HIV: the lifesaving story of Robert W.

Presenting with a CD4 count of only 21, doctors gave Robert W. mere months to live. Weighing only 98 pounds, his HIV had progressed to Stage 3 AIDS, and he was on his deathbed. Robert had been prescribed seven different HIV medications and had a long history of struggling with his HIV treatment compliance due to the complexity of his therapy coupled with the financial burdens of high co-pays.

Though he wanted to get better, he had to make decisions on which medications to buy based on what he could afford. Years of treating his condition with this hodgepodge approach left him resistant to many of the medications that could effectively treat his HIV. His roadblocks to adherence reached a crescendo when the loss of a brother he was close to left him hopeless and stripped his will to fight. Complicating Robert’s case was that he had developed coronary artery disease and needed a bypass, but surgeons could not consider him a candidate for the procedure until his HIV viral load became undetectable. Knowing that heart disease was what claimed his brother’s life at the age of 50, Robert gave up hope and lost his will to live. He was on the sidelines of a tragic race that would determine which condition would claim his life first: AIDS or heart disease.

This was Robert’s condition when he enrolled with in our Patient Management Program for HIV treatment.

Restoring access to HIV treatment and revitalizing Robert’s will to live.

The team at Curant immediately went to work partnering with his team of clinicians at Virginia Commonwealth University to eliminate the roadblocks to HIV treatment compliance that were killing Robert. His medications were aggregated and sent in bubble packs to simplify the dosing schedule, making it easy for him to adhere to his prescribed therapy, even on the days when it seemed overwhelming to think about it. As part of Curant’s outreach program, a clinician spoke to him every month to ensure he had no problems and was remaining compliant. She was his friendly reminder, a voice of compassion and knowledge that served equal parts encouragement and information source.

But the most important roadblock Curant removed was financial. Even though he was covered by insurance, Robert faced medication co-pays totaling $700 per month. Since he received treatment at a 340B-covered clinic, Curant notified VCU that its 340B funds could be used pay Robert’s co-pays. It did so, and Robert no longer had to worry about how he was going to afford the HIV treatment and medications that would save his life.

For the time, he had full access to all of the medication he needed at the same time.

With fully covered medication, easy to administer bubble packs, and monthly check-ins, Robert began a remarkable recovery that surprised and delighted his healthcare team. By July, his CD4 count rose to 96. More importantly, his viral load became undetectable, making him a candidate to receive the bypass surgery he needs to treat his heart disease. Robert is currently preparing to develop a plan to treat his coronary artery disease and he weighs a healthy 188 pounds with no timeframe on how long he may live.

Assuming his bypass surgery is successful, Robert is likely to enjoy a normal lifespan.